Literature DB >> 21042775

MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein.

Yanhui Lou1, Xingsheng Yang, Fuling Wang, Zhumei Cui, Yu Huang.   

Abstract

Ovarian cancer, especially epithelial ovarian cancer (EOC), which accounts for 90% of ovarian cancer, continues to be the leading cause of death among gynecological malignancies. However, the factors associated with its malignant biological behavior are still poorly understood. Accumulating evidence suggests that microRNAs (miRNAs), regulating diverse biological processes, may play an important role in tumorigenesis and development. miR-21 has been frequently observed to be aberrantly overexpressed in various tumors. Using real-time PCR, we confirmed that miR-21 was significantly overexpressed in human EOC tissues and cell lines. The overexpression of miR-21 correlated with histological differentiation, clinicopathological stage, and lymph node metastasis, and we showed that knockdown of miR-21 by an inhibitor caused a significant reduction in cell proliferation and decrease in cell migration and invasion abilities. Furthermore, we demonstrated that knockdown of miR-21 significantly increased the expression of PTEN, a known tumor suppressor in ovarian cancer. Collectively, our findings suggest miR-21 may be important in the initiation and progression of EOC as an oncomiR, likely through regulating PTEN.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21042775     DOI: 10.3892/ijmm_00000530

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  75 in total

1.  MicroRNA profiling identifies miR-29 as a regulator of disease-associated pathways in experimental biliary atresia.

Authors:  Nicholas J Hand; Amber M Horner; Zankhana R Master; LaTasha A Boateng; Claire LeGuen; Marina Uvaydova; Joshua R Friedman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-02       Impact factor: 2.839

2.  Nicotine upregulates microRNA-21 and promotes TGF-β-dependent epithelial-mesenchymal transition of esophageal cancer cells.

Authors:  Yi Zhang; Tiecheng Pan; Xiaoxuan Zhong; Cai Cheng
Journal:  Tumour Biol       Date:  2014-04-23

3.  miRNA-21 enhances chemoresistance to cisplatin in epithelial ovarian cancer by negatively regulating PTEN.

Authors:  Xiaomin Yu; Yulong Chen; Ruiyun Tian; Jianxia Li; Hongyan Li; Teng Lv; Qin Yao
Journal:  Oncol Lett       Date:  2017-06-07       Impact factor: 2.967

4.  A syntenic locus on buffalo chromosome 20: novel genomic hotspot for miRNAs involved in follicular-luteal transition.

Authors:  Vijay Simha Baddela; Suneel Kumar Onteru; Dheer Singh
Journal:  Funct Integr Genomics       Date:  2016-11-19       Impact factor: 3.410

5.  MicroRNA-19b promotes the migration and invasion of ovarian cancer cells by inhibiting the PTEN/AKT signaling pathway.

Authors:  Dan-Tong Liu; Hai-Rong Yao; Yan-Ying Li; Yang-Yang Song; Meng-Ya Su
Journal:  Oncol Lett       Date:  2018-05-10       Impact factor: 2.967

Review 6.  Therapies targeting cancer stem cells: Current trends and future challenges.

Authors:  Denisa L Dragu; Laura G Necula; Coralia Bleotu; Carmen C Diaconu; Mihaela Chivu-Economescu
Journal:  World J Stem Cells       Date:  2015-10-26       Impact factor: 5.326

Review 7.  Regulation of microRNAs in cancer metastasis.

Authors:  Juliette M C Bouyssou; Salomon Manier; Daisy Huynh; Samar Issa; Aldo M Roccaro; Irene M Ghobrial
Journal:  Biochim Biophys Acta       Date:  2014-02-22

Review 8.  Small molecule compounds targeting miRNAs for cancer therapy.

Authors:  Paloma Del C Monroig; Lu Chen; Shuxing Zhang; George A Calin
Journal:  Adv Drug Deliv Rev       Date:  2014-09-17       Impact factor: 15.470

9.  Set9, NF-κB, and microRNA-21 mediate berberine-induced apoptosis of human multiple myeloma cells.

Authors:  Hai-yan Hu; Kun-peng Li; Xiu-ju Wang; Yuan Liu; Zhi-gang Lu; Rui-hong Dong; Hong-bo Guo; Mei-xia Zhang
Journal:  Acta Pharmacol Sin       Date:  2012-12-17       Impact factor: 6.150

10.  miRNA-Based Therapeutic Strategies.

Authors:  Masaharu Ishida; Florin M Selaru
Journal:  Curr Anesthesiol Rep       Date:  2012-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.